Release Date: 31/05/21 15:51 Summary: Announcement of buy-back - Appendix 3C Price Sensitive: Yes Download Document 265.86KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%